Ex Vivo Formation of Blood Vessels

Vascular bypass grafts represent a well-grounded technological advance in the new millennium, this being related to the high prevalence of atherosclerosis and the ensuing treatment of myocardial infarction [1]. However, more recently a paradigm shift has

  • PDF / 513,789 Bytes
  • 8 Pages / 547.087 x 737.008 pts Page_size
  • 71 Downloads / 222 Views

DOWNLOAD

REPORT


ntents 47.1

Introduction  . . . . . . . . . . . . . . . . . . . . . . . .   685

47.2

Ideal Vascular Graft  . . . . . . . . . . . . . . . . . .   686

47.3

Tissue-Engineered Vascular Grafts  . . . . . .   686

47.3.1 Scaffold  . . . . . . . . . . . . . . . . . . . . . . . . . . .   687 47.3.2 Matrix  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   688 47.3.3 Endothelialisation  . . . . . . . . . . . . . . . . . . . .   689 47.4

Current Problems  . . . . . . . . . . . . . . . . . . . .   689

47.5

Conclusion  . . . . . . . . . . . . . . . . . . . . . . . . .   690 References  . . . . . . . . . . . . . . . . . . . . . . . . .   691

47.1

Introduction

Vascular bypass grafts represent a well-grounded technological advance in the new millennium, this being related to the high prevalence of atherosclerosis and the ensuing treatment of myocardial infarction [1]. However, more recently a paradigm shift has occurred casting the subject of vascular tissue engineering in new light. The development of cardiovascular devices both for high- and low-flow scenarios in the form of functional vascular prostheses has

47

made this possible. While the patency rates of highflow vessels [2], such as polyethylene terephthalate (Dacron) and expanded polytetrafluoroethylene (ePTFE) grafts following prolonged clinical use are acceptable, these figures are less satisfactory at lower flow rates [3]. Given the limitations with synthetic materials alone, a biological or biohybrid vascular prosthesis could provide us with the ideal blood vessel substitute. The current interest in developing artificial organs such as the tissue-engineered bladders [4] and composite tissue has sparked renewed interest in this field. In the latter case, the limitations of immunogenicity with allotransplantation [5] have put the development of these blood vessels, and in particular the development of artificial capillary systems [6], at the forefront. Such integrated vascular networks would serve to nourish the various tissue planes within a tissue-engineered construct [7]. This has formed the basis for the emphasis of developing small-calibre (